Background: Missed gastric cancer (MGC) is poorly documented in Mediterranean populations.
Aims: (1) To assess the rate, predictors and survival of MGC. (2) To compare MGC and non-MGC tumors.
Methods: This is a retrospective-cohort study conducted at four centers. MGC was defined as cancer detected within three years after negative esophagogastroduodenoscopy. Gastric adenocarcinomas diagnosed between 2008-2015 were included. Patients with no follow-up were excluded.
Results: During the study period 123,395 esophagogastroduodenoscopies were performed, with 1374 gastric cancers being diagnosed (1.1%). A total of 1289 gastric cancers were finally included. The overall rate of MGC was 4.7% (61/1289, 3.7-6%). A negative esophagogastroduodenoscopy in MGC patients was independently associated with PPI therapy (p < 0.001), previous Billroth II anastomosis (p = 0.002), and lack of alarm symptoms (p < 0.001). The most frequent location for MGC was the gastric body(52.4%). MGCs were smaller than non-MGCs (31 vs 41 mm, p = 0.047), more often flat or depressed (p = 0.003) and less likely to be encountered as advanced disease. Overall 2-year survival was similar between MGC (34.1%) and Non-MGC (35.3 %) (p = 0.59).
Conclusion: MGC accounted for nearly five percent of newly-diagnosed gastric adenocarcinomas. Overall survival was poor and not different between MGC and non-MGC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.dld.2019.02.006 | DOI Listing |
Cancer Res Treat
December 2024
Division of Gastroenterology, Department of Internal Medicine, Center for Cancer Prevention and Detection, National Cancer Center, Goyang, Korea.
Purpose: Gastric cancer (GC) prediction models hold potential for enhancing early detection by enabling the identification of high-risk individuals, facilitating personalized risk-based screening, and optimizing the allocation of healthcare resources.
Materials And Methods: In this study, we developed a machine learning-based GC prediction model utilizing data from the Korean National Health Insurance Service, encompassing 10,515,949 adults who had not been diagnosed with GC and underwent GC screening during 2013-2014, with a follow-up period of at least five years. The cohort was divided into training and test datasets at an 8:2 ratio, and class imbalance was mitigated through random oversampling.
Gastrointest Endosc
December 2024
Department of Genetics,; Clinical Cancer Genetics Program,; Department of Gastrointestinal Medical Oncology, ; Department of Immunology. The University of Texas MD Anderson Cancer Center, TX 77030, USA. Electronic address:
Cureus
November 2024
Department of Emergency and Hospital Medicine, Lehigh Valley Health Network, Allentown, USA.
Cameron lesions are a unique and relatively rare cause of upper gastrointestinal bleeding that appears in the mucosa of the gastric body in the presence of a large hiatal hernia. These lesions can be a source of occult bleeding and subsequent chronic iron deficiency anemia (IDA) but may often be missed on initial endoscopy, requiring repeat studies to diagnose. Prompt treatment for Cameron lesions is necessary to avoid the high mortality rate associated with them.
View Article and Find Full Text PDFPathologie (Heidelb)
December 2024
Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
Front Oncol
November 2024
The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!